目前中国专职从事创新药物研究的人员不足三千人，仅相当于美国默克药厂研究部的在编人员。

• Now, in China, there are less than 3,000 full time personnel engaging in the research of innovated medicines, only corresponding to personnel on the regular payroll of the research department of Merck Pharmaceutical Company of the US.